ASX Announcement

1st patient dosed in TLX250-CDx study in Bladder Cancer

Published: 23/06/21, 09:03am (AEST)2 pages
Telix Pharmaceuticals Limited
TLX:ASXHealthcare

Recent TLX Announcements

Price Sensitive only